About BTCI     

---

Mission Statement:

Contributing to the continued success of the biotechnology industry and to efforts aimed at enhancing the quality of education in the life sciences and of education overall -- building and strengthening communities which support lifelong learning.

Overview:

Founded in 1993, the BioPharmaceutical Technology Center Institute (BTCI) is a non-profit, tax exempt, independent organization, which shares the BioPharmaceutical Technology Center (BTC) with Promega Corporation. Located in Madison, Wisconsin, more than 20,000 square feet of the BTC is designated for educational, scientific and cultural purposes. This includes a 291-seat auditorium, meeting rooms, classrooms, and laboratories for supporting biotechnology training and education. As indicated in its Statement of Purpose, BTCI exists to:

• offer training in biotechnology and biopharmaceutical manufacturing;
• promote the exchange of information between industry, educators and the general public;
• support the development of high technology industries;
• facilitate science, technology, nature discovery and arts programs for children and young adults;
• encourage greater understanding of the creative process;
• enable community organizations to offer educational and cultural programs.

See also:

• Statement of Purpose
• Board of Directors
• Staff
• Program Partners 2006/2007
• Promega/Hannam BTCI partnership at Hannam University, Daejeon, Korea

Contact: Dr. Karin Borgh, Executive Director
BioPharmaceutical Technology Center Institute (BTCI)
5445 East Cheryl Parkway
Madison, Wisconsin, USA 53711
608-277-2508; FAX:608-273-6992
e-mail: karin.borgh@btci.org